mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
mRNA |
NU-7441 |
GDSC1000 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |